Home News & Events Events Events Filter events Filter events by clicking within the ‘Category’ drop-down list. Category - Any -IndustryWebinarsWorkshop Previous 1 2 In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related Information Webpage Webinars Webpage Industry Events Webpage Workshops What’s happening in ICON ICON Plc GLP-1 receptor agonists have established compelling evidence for the commercial value of multi-indication drug development beyond obesity. Conventional paradigms for drug development must shift in order to adapt to multi... 14h View post View webpage ICON Plc Smarter oversight starts with smarter tools. ICON’s latest blog shows how tech enables agile, risk-based quality management in clinical trials. Explore the future of RBQM: https://ow.ly/wrH550XgO1g 14h 2 View post View webpage ICON Plc October is intimate partner violence awareness month (IPV). IPV affects millions globally, yet its impact on clinical trial participation and outcomes remains largely unexamined. As the industry continues to advance equ... 16h 1 View post View webpage ICON Plc Latest issue out now. Keep up to date on the latest changes with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribers who have discovered the convenience of this free monthly publication by signing u... 16h 2 View post View webpage ICON Plc New research shows that clinical trials with digital endpoints can be completed 3 to 5 months faster than those without. This can be a difference worth millions. But the benefits of leveraging digital don’t end there. R... 17h View post View webpage ICON Plc ICON brings a comprehensive approach to obesity asset development, from imaging and diagnostics to adjudication strategies, device experience, and vendor solutions. Visit us at Obesity Week, Nov 4-7 at booth 520 to explo... 18h 1 View post View webpage ICON Plc ICON leverages real-world evidence to uncover prescriber behavior, payer influence, and patient needs by identifying key subpopulations and quantifying therapeutic impact to build stronger value propositions. Arrange a t... 18h View post View webpage ICON Plc “Off-the-shelf” scalability, decentralised manufacturing, and regulatory harmonisation—ICON’s leaders explore what it takes to build a sustainable CGT ecosystem in APAC in the article. https://ow.ly/uF3950XgMK6 19h View post View webpage ICON Plc A successful JCA submission starts with the right evidence. Learn how to align your clinical data with the PICO framework and meet the expectations of EU regulators. Read our whitepaper for actionable guidance: https://... 20h 2 View post View webpage ICON Plc ICON’s new whitepaper reveals how smarter monitoring models and evolving CRA roles are reducing trial delays, improving site performance and enabling real-time oversight. Download now: https://lnkd.in/eJcZvnkV 21h View post View webpage ICON Plc From risk-based quality management to tech integration - ICH GCP E6(R3) changes everything. Our article in PharmaTimes outlines how a robust impact assessment sets the foundation for successful implementation. Start smar... 22h View post View webpage ICON Plc ICH GCP E6(R3) brings major updates to clinical trial standards. From tech integration to participant protection, the changes are wide-ranging. Our PharmaTimes article shows how a strong impact assessment can guide your ... 22h 1 View post View webpage
